1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hua, Y. Kuhlman, B. Hoffman, D. Raleigh, D.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.0 90.0 90.0 1.0 1.0 1.0 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 289 167 174 10.1006/jmbi.1999.2742 10339414 Effects of varying the local propensity to form secondary structure on the stability and folding kinetics of a rapid folding mixed alpha/beta protein: characterization of a truncation mutant of the N-terminal domain of the ribosomal protein L9. 1999 IX Eur.J.Biochem. EJBCAI 0262 0014-2956 13 205 Crystal Structure of Prokaryotic Ribosomal Protein L9: A Bi-Lobed RNA-Binding Protein 1994 10.2210/pdb1cqu/pdb pdb_00001cqu 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6231.309 50S RIBOSOMAL PROTEIN L9 N-TERMINAL DOMAIN 1 nat polymer no no MKVIFLKDVKGKGKKGEIKNVADGYANNFLFKQGLAIEATPANLKALEAQKQKEQR MKVIFLKDVKGKGKKGEIKNVADGYANNFLFKQGLAIEATPANLKALEAQKQKEQR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Geobacillus sample 1422 Geobacillus stearothermophilus database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2002-04-27 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession RCSB Y RCSB 1999-08-11 REL REL structures with the least restraint violations 50 18 2D NOESY 5.0 AMBIENT 298 K DISTANCE GEOMETRY SIMULATED ANNEALING BRUNGER structure calculation X-PLOR 3.81 BRUNGER refinement X-PLOR 3.81 600 Varian INOVA MET 1 n 1 MET 1 A LYS 2 n 2 LYS 2 A VAL 3 n 3 VAL 3 A ILE 4 n 4 ILE 4 A PHE 5 n 5 PHE 5 A LEU 6 n 6 LEU 6 A LYS 7 n 7 LYS 7 A ASP 8 n 8 ASP 8 A VAL 9 n 9 VAL 9 A LYS 10 n 10 LYS 10 A GLY 11 n 11 GLY 11 A LYS 12 n 12 LYS 12 A GLY 13 n 13 GLY 13 A LYS 14 n 14 LYS 14 A LYS 15 n 15 LYS 15 A GLY 16 n 16 GLY 16 A GLU 17 n 17 GLU 17 A ILE 18 n 18 ILE 18 A LYS 19 n 19 LYS 19 A ASN 20 n 20 ASN 20 A VAL 21 n 21 VAL 21 A ALA 22 n 22 ALA 22 A ASP 23 n 23 ASP 23 A GLY 24 n 24 GLY 24 A TYR 25 n 25 TYR 25 A ALA 26 n 26 ALA 26 A ASN 27 n 27 ASN 27 A ASN 28 n 28 ASN 28 A PHE 29 n 29 PHE 29 A LEU 30 n 30 LEU 30 A PHE 31 n 31 PHE 31 A LYS 32 n 32 LYS 32 A GLN 33 n 33 GLN 33 A GLY 34 n 34 GLY 34 A LEU 35 n 35 LEU 35 A ALA 36 n 36 ALA 36 A ILE 37 n 37 ILE 37 A GLU 38 n 38 GLU 38 A ALA 39 n 39 ALA 39 A THR 40 n 40 THR 40 A PRO 41 n 41 PRO 41 A ALA 42 n 42 ALA 42 A ASN 43 n 43 ASN 43 A LEU 44 n 44 LEU 44 A LYS 45 n 45 LYS 45 A ALA 46 n 46 ALA 46 A LEU 47 n 47 LEU 47 A GLU 48 n 48 GLU 48 A ALA 49 n 49 ALA 49 A GLN 50 n 50 GLN 50 A LYS 51 n 51 LYS 51 A GLN 52 n 52 GLN 52 A LYS 53 n 53 LYS 53 A GLU 54 n 54 GLU 54 A GLN 55 n 55 GLN 55 A ARG 56 n 56 ARG 56 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 19 A N LYS 19 A O VAL 3 A O VAL 3 A N ILE 4 A N ILE 4 A O ILE 37 A O ILE 37 1 A A H2 OD1 MET ASP 1 23 1.50 1 A A O H ALA GLN 46 50 1.57 2 A A O H TYR ASN 25 28 1.45 3 A A O H TYR ASN 25 28 1.50 4 A A O H TYR ASN 25 28 1.48 4 A A H O VAL GLY 9 13 1.53 5 A A O H VAL GLY 9 11 1.46 5 A A O H TYR ASN 25 28 1.46 7 A A O H TYR ASN 25 28 1.56 9 A A O H TYR ASN 25 28 1.57 10 A A O H TYR ASN 25 28 1.44 12 A A O H ALA GLN 46 50 1.47 12 A A O H TYR ASN 25 28 1.57 13 A A O H TYR ASN 25 28 1.58 14 A A O H ALA GLN 46 50 1.50 14 A A O H GLU THR 38 40 1.53 14 A A O H VAL GLY 9 11 1.59 15 A A HZ2 OD1 LYS ASN 19 20 1.46 16 A A HA H VAL GLY 9 13 1.34 16 A A O H TYR ASN 25 28 1.42 16 A A O H VAL GLY 9 11 1.56 16 A A O O LYS GLY 7 13 2.14 16 A A C O ASP GLY 8 13 2.17 17 A A O H TYR ASN 25 28 1.55 18 A A O H GLU LYS 48 51 1.58 1 A ARG 56 0.308 SIDE CHAIN 2 A ARG 56 0.299 SIDE CHAIN 3 A ARG 56 0.277 SIDE CHAIN 4 A ARG 56 0.115 SIDE CHAIN 6 A ARG 56 0.306 SIDE CHAIN 7 A ARG 56 0.277 SIDE CHAIN 8 A ARG 56 0.249 SIDE CHAIN 9 A ARG 56 0.111 SIDE CHAIN 10 A ARG 56 0.236 SIDE CHAIN 11 A ARG 56 0.303 SIDE CHAIN 12 A ARG 56 0.127 SIDE CHAIN 13 A ARG 56 0.172 SIDE CHAIN 14 A ARG 56 0.218 SIDE CHAIN 15 A ARG 56 0.317 SIDE CHAIN 16 A ARG 56 0.187 SIDE CHAIN 17 A ARG 56 0.318 SIDE CHAIN 18 A ARG 56 0.079 SIDE CHAIN 5 -13.75 2.10 128.40 114.65 A A A C N CD THR PRO PRO 40 41 41 Y 1 A LYS 2 -49.66 151.25 1 A VAL 9 -123.24 -142.15 1 A LYS 15 -32.85 137.28 1 A VAL 21 -86.94 -143.39 1 A ASP 23 -31.61 -31.16 1 A ALA 26 -29.78 -61.52 1 A PHE 29 -160.96 -52.68 1 A GLN 33 -133.22 -93.20 1 A GLU 38 -56.17 108.73 1 A LYS 53 -131.66 -100.58 2 A LYS 2 -49.23 152.12 2 A VAL 9 -97.32 -155.42 2 A LYS 19 -161.83 -125.88 2 A VAL 21 -86.78 -147.01 2 A ASP 23 -31.36 -31.63 2 A PHE 29 -161.32 -47.07 2 A GLN 33 -107.94 -100.87 2 A ALA 39 -54.39 95.33 2 A GLU 54 -145.23 -83.80 2 A GLN 55 -159.98 24.84 3 A LYS 2 -49.45 156.70 3 A VAL 9 -116.12 -146.45 3 A LYS 12 -120.30 -70.67 3 A LYS 19 -161.68 -124.27 3 A VAL 21 -86.36 -140.64 3 A ASP 23 -29.46 -34.22 3 A ALA 26 -28.75 -58.26 3 A PHE 29 -151.61 -46.86 3 A GLU 38 -51.04 108.83 3 A ALA 39 -49.33 100.22 3 A GLN 52 -48.32 104.19 3 A LYS 53 -85.80 41.10 4 A LYS 12 -137.74 -41.69 4 A LYS 19 -161.17 -127.53 4 A VAL 21 -87.48 -146.57 4 A ASP 23 -30.65 -32.28 4 A ALA 26 -29.39 -60.23 4 A PHE 29 -160.65 -52.83 4 A GLU 38 -38.65 113.83 4 A ALA 39 -48.58 99.24 4 A GLN 52 -73.01 -78.30 4 A LYS 53 -58.16 89.84 5 A LYS 7 -95.72 -152.52 5 A LYS 10 -64.72 70.12 5 A LYS 12 -151.15 -87.06 5 A LYS 15 -28.70 121.32 5 A LYS 19 -161.54 -127.87 5 A VAL 21 -87.55 -149.29 5 A ASP 23 -30.59 -31.53 5 A PHE 29 -160.56 -52.88 5 A LYS 32 -69.95 0.28 5 A GLU 38 -55.11 105.06 5 A ALA 39 -54.17 89.79 5 A ALA 42 -36.10 -35.13 5 A LYS 53 -53.45 -72.36 6 A VAL 9 -130.92 -157.81 6 A LYS 15 -37.95 134.43 6 A LYS 19 -160.97 -126.37 6 A VAL 21 -87.23 -143.89 6 A ASP 23 -31.42 -30.52 6 A ALA 26 -28.69 -60.60 6 A ASN 27 -89.30 34.03 6 A PHE 29 -160.69 -46.42 6 A GLN 33 -127.97 -114.31 6 A GLU 38 -37.05 108.94 6 A ALA 39 -55.97 97.85 6 A GLN 55 -137.28 -31.36 7 A LYS 7 -118.65 -163.75 7 A VAL 9 -124.89 -162.74 7 A LYS 10 -65.74 83.05 7 A LYS 12 -108.54 -67.61 7 A VAL 21 -87.14 -144.56 7 A ASP 23 -31.51 -31.20 7 A PHE 29 -161.17 -46.78 7 A GLN 33 -114.57 -92.89 7 A ALA 39 -59.21 83.85 7 A ALA 42 -36.52 -30.15 7 A ASN 43 -93.71 -60.65 7 A GLN 55 -147.83 -41.04 8 A LYS 10 -56.24 82.93 8 A LYS 12 -142.99 -61.44 8 A VAL 21 -87.25 -150.20 8 A ASP 23 -30.86 -32.24 8 A ALA 26 -29.25 -57.41 8 A PHE 29 -160.31 -99.58 8 A LEU 30 -29.81 -42.48 8 A ALA 39 -54.40 99.91 8 A GLN 52 -53.40 -174.35 8 A GLN 55 -159.96 22.84 9 A LYS 7 -117.76 -165.75 9 A VAL 9 -99.66 -154.98 9 A LYS 12 -126.45 -67.80 9 A LYS 19 -160.99 -127.09 9 A VAL 21 -87.02 -141.37 9 A ASP 23 -31.16 -32.31 9 A ALA 26 -29.44 -64.08 9 A ASN 27 -89.75 33.54 9 A PHE 29 -160.73 -49.48 9 A GLN 33 -123.90 -111.16 9 A ALA 39 -51.31 97.17 9 A GLU 54 -145.48 -51.01 9 A GLN 55 -160.15 48.89 10 A VAL 9 -125.72 -143.96 10 A LYS 12 -146.06 -75.71 10 A LYS 19 -161.00 -128.96 10 A VAL 21 -87.51 -146.53 10 A ASP 23 -32.24 -29.88 10 A ALA 26 -29.39 -60.39 10 A PHE 29 -161.24 -58.59 10 A GLU 38 -59.66 107.17 10 A ALA 39 -63.64 96.88 10 A LEU 47 -38.84 -27.73 10 A GLU 54 -158.80 -80.56 11 A LYS 7 -115.31 -163.39 11 A VAL 9 -121.18 -158.74 11 A VAL 21 -87.54 -144.49 11 A ASP 23 -33.57 -30.54 11 A ALA 26 -29.01 -59.21 11 A PHE 29 -160.71 -77.51 11 A ALA 39 -49.53 107.07 11 A GLN 52 -66.33 -149.43 11 A LYS 53 -57.93 -171.08 11 A GLN 55 -155.97 27.56 12 A LYS 7 -115.81 -166.16 12 A LYS 12 -151.55 -25.55 12 A LYS 19 -161.79 -121.87 12 A VAL 21 -86.78 -144.79 12 A ASP 23 -30.38 -33.06 12 A PHE 29 -161.01 -43.90 12 A GLN 33 -113.89 -105.70 12 A GLU 38 -38.85 116.96 12 A LYS 53 -157.03 71.67 12 A GLN 55 -140.64 19.37 13 A VAL 9 -106.96 -157.77 13 A LYS 10 -61.73 76.33 13 A LYS 12 -131.65 -83.73 13 A LYS 19 -161.54 -125.72 13 A VAL 21 -87.33 -142.32 13 A ASP 23 -31.66 -31.46 13 A PHE 29 -161.33 -50.85 13 A GLN 33 -114.33 -88.60 13 A GLU 38 -39.49 115.04 13 A ALA 39 -48.34 102.21 13 A LYS 53 -99.74 -131.34 13 A GLN 55 -157.74 73.16 14 A LYS 10 -67.13 62.81 14 A LYS 19 -160.79 -127.82 14 A VAL 21 -86.89 -142.66 14 A ASP 23 -29.67 -37.30 14 A ALA 26 -29.97 -63.94 14 A ASN 27 -88.68 35.31 14 A PHE 29 -160.74 -47.24 14 A GLN 33 -116.72 -92.13 14 A ALA 39 -66.99 60.64 14 A GLN 52 -61.98 -170.69 14 A GLN 55 -150.64 44.06 15 A LYS 7 -121.97 -164.58 15 A LYS 10 -54.09 85.32 15 A LYS 12 -146.72 -32.83 15 A LYS 19 -161.40 -130.93 15 A VAL 21 -86.88 -144.06 15 A ASP 23 -32.05 -30.33 15 A ALA 26 -29.57 -64.48 15 A ASN 28 -157.94 -32.35 15 A GLN 33 -118.84 -102.22 15 A GLU 38 -51.06 108.88 15 A ALA 39 -49.94 96.07 15 A GLN 55 -149.26 -41.39 16 A LYS 7 -108.98 -142.86 16 A LYS 12 -151.03 -18.97 16 A LYS 15 -29.81 122.03 16 A LYS 19 -160.96 -129.94 16 A VAL 21 -87.07 -142.85 16 A ASP 23 -32.72 -30.13 16 A ALA 26 -28.75 -58.49 16 A PHE 29 -159.93 -53.00 16 A GLN 33 -106.39 -90.06 16 A ALA 39 -51.76 96.09 16 A LEU 44 -39.20 -37.77 16 A GLN 52 -66.91 95.88 16 A GLN 55 -152.08 35.37 17 A LYS 15 -34.33 135.06 17 A LYS 19 -159.89 -130.28 17 A VAL 21 -86.62 -145.73 17 A ASP 23 -30.80 -30.48 17 A ALA 26 -29.89 -63.57 17 A PHE 29 -135.68 -43.09 17 A GLN 33 -124.61 -103.08 17 A GLU 38 -58.28 107.97 17 A ALA 39 -59.25 93.18 17 A GLU 54 -93.11 -107.00 17 A GLN 55 -151.05 19.46 18 A LYS 12 -135.35 -55.16 18 A LYS 19 -161.22 -129.98 18 A VAL 21 -87.34 -146.80 18 A ASP 23 -29.34 -36.68 18 A ALA 26 -29.46 -64.34 18 A ASN 28 -154.89 -31.32 18 A PHE 29 -130.69 -42.81 18 A GLN 33 -120.02 -93.78 18 A ALA 39 -57.20 82.79 18 A LYS 53 -102.59 -159.97 18 A GLU 54 -59.58 -70.58 18 A GLN 55 -144.32 41.52 SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L9 1 N N A GLY 24 A GLY 24 HELX_P A PHE 29 A PHE 29 1 1 6 A THR 40 A THR 40 HELX_P A GLN 50 A GLN 50 1 2 11 RIBOSOME PROTEIN L9, RIBOSOME RL9_BACST UNP 1 P02417 1 56 1CQU 1 56 P02417 A 1 1 56 3 anti-parallel anti-parallel A GLU 17 A GLU 17 A ASN 20 A ASN 20 A LYS 2 A LYS 2 A PHE 5 A PHE 5 A ALA 36 A ALA 36 A GLU 38 A GLU 38 1 P 1